SUMMARY This study describes the newly discovered relation between ejection fraction and endsystolic volume index (ESVI) of the left ventricle as obtained by angiography at the time of cardiac catheterisation. Linear regression analysis shows that ejection fraction (%)=82 0-0 62 ESVI (ml/m2) but the correlation for patients receiving beta-adrenergic blocking drugs is significantly lower compared with the untreated group. Non-linear analysis, applied to cover also the asymptotic range for ejection fraction <20%, shows similar results. The good relation between the two indices indicates that the index ejection fraction may derive its clinical importance directly from the more fundamental index end-systolic volume index by virtue ofthe operation ofthe beta-adrenergic system on the heart. Generally, ejection fraction has been accepted clinically as a useful index to assess ventricular performance.
Generally, ejection fraction has been accepted clinically as a useful index to assess ventricular performance. I To date, no basis other than empirical observations has been provided on which the importance2 of ejection fraction is founded. Moreover, some investigators have questioned seriously the relevance of ejection fraction as a unique discriminator ofventricular performance.34 End-diastolic volume index (EDVI) has been regarded as a primary determinant of ventricular function, mainly in conjunction with the Frank-Starling law of the heart. Several studies have shown a more or less hyperbolic relation between ejection fraction and enddiastolic volume index.5-7 Recently, however, considerable attention has been given to systolic events during the cardiac cycle, and particularly to the endsystolic volume index89 and related quantities such as systolic elastance. [10] [11] [12] Since end-systolic volume is the volume to which the heart is able to contract under given conditions of preload and afterload this index is just as fundamental as end-diastolic volume to judge cardiac performance. Consequently, it seems logical to investigate the relation between the two systolic indices, ejection fraction and end-systolic volume index (ESVI). The present study documents a remarkable relation between the empirical index ejection fraction and the functional variable end-systolic volume index in a large group of patients. In addition, the effect of adrenergic blockade on this relation is studied by way ofanalysis ofa separate group ofpatients under chronic treatment with beta-blockade.
Patients and methods
The population under consideration consisted of 165 unselected patients having angina and admitted to our clinic for medical examination. Their suitability for coronary bypass surgery was evaluated by selective angiocardiography, employing the Judkins technique. Fifty-two patients were not receiving any sympatholytic medication, while all the others (113) continued to receive their usual doses of beta-adrenergic blocking agents during the period of diagnostic catheterisation. Left ventricular cavity volume was determined angiographically using the right anterior oblique projection and the area-length method of Dodge,"' in combination with correction terms, derived from studies by Lange and coworkers,'4 yielding V=1=0-72 Vmed -4*7 ml. Volumes were normalised for body surface area to obtain end-systolic and end-diastolic volume indices, expressed as ml/ml. Ejection fraction (EF) was calculated using the definition formula EF=1-EVSI/ EDVI. Details of the methods used have been extensively described previously.9 Briefly, standard linear and non-linear regression methods were applied to describe the correlation of ejection fraction to endsystolic volume index and end-diastolic volume index. Basically, simple linear regression analysis may be applied to these data, as long as ejection fraction is not within the asymptotic region below 20%. As documented previously,9 asymptotic behaviour may be present for data points in the latter region. On The asymptotic region is defined here as that area below the ejection fraction=20% line where, in addition, end-systolic volume index values are beyond the range determined by the 2 SEE (twice standard error of the estimate) line calculated on the basis of the regression line obtained by pooling all data points having ejection fractions ofmore than 20%. Differences between regression coefficients were analysed using the Student t distribution, and the significance of different r values was tested using the Fisher z-transformation.
Results
Ejection fraction and end-systolic volume index values for both patient groups are shown in Fig. 1 and 2, along with their linearised and quadratic regression curves. In our study, 156 patients had an ejection fraction greater than 20%, thus yielding a 2 SEE line given by EF(%)=97-5-0-66 ESVI (ml/m2) This procedure gives three deviating data points in our study as marked by the square symbols in Fig. 1 , indicating that over a wide range of values of endsystolic volume values the relation between ejection fraction and end-systolic volume index may be fairly well approximated by a linearised approach, yielding an overall linear correlation coefficient of -0-899 (Table) for 162 patients, while neglecting three data points (squares in Fig. 1 ) in the asymptotic region. It should be noted that in this asymptotic region the variable ejection fraction is about equal for patients with widely varying end-systolic and end-diastolic volume indices, which may imply that in these cases the ejection fraction is not an unambiguous index of left ventricular function. To allow for aligned comparison of the two groups, we decided to discard these three points, and to concentrate primarily on the linearised region of the ejection fraction vs. end-systolic volume index curves. After these patients were subdivided into groups, namely those untreated and those treated with beta-blocking agents, the following results were obtained: If the procedure of omitting the three asymptotic points is abandoned, it is necessary to apply non-linear regression analysis. Quadratic analysis confirms that ejection fraction and end-systolic volume indexes are again excellently correlated, and also that the correlation coefficient is reduced for the group of patients under chronic beta-blockade. The difference of the correlation coefficients is similarly significant (p<0002).
When ejection fraction is plotted as a function of end-diastolic volume index for our patients, a poor linear correlation is found. The r value is only -0-56 when all 162 patients are considered (Table) , while r= -0 39 (Fig. 3) for the treated and r= -0 66 (Fig. 4) for the untreated groups, respectively. Not only was a high correlation absent, but in addition it was impossible to recognise a hyperbolic or any other nonlinear relation for these collections of data points. The 
Discussion
Regression analysis applied to volumetric data from our patients discloses that ejection fraction and endsystolic volume index are highly correlated. For the range of ejection fraction values of main interest (that is above about 20%) the relation can be fairly well approximated by a linearised description. A quadratic approach turned out to be necessary in order to take into account the asymptotic part at the higher endsystolic volume index region. To our knowledge, no previous investigators have discovered this remarkable relation. Analysis9 of data collected from studies by other investigators strikingly confirmed our observations with respect to the excellent relation between ejection fraction and end-systolic volume index.
In addition, the effects of beta-blocking agents on this relation were investigated. Most studies of betaadrenergic blockade are concerned with effects on heart rate, cardiac output, and blood pressure, while only limited information with respect to the effects on left ventricular volume is available. We were unable to find published data providing sufficient information to allow for due statistical comparison of groups of patients with and without beta-adrenergic blockade. Therefore, our study was designed to cover numbers of patients in both groups which enabled firm statistical statements with respect to different r values for regression analysis applied to both groups. Ideally, this type of research should be carried out on one single group, serving as its own control. Since we are considering chronic effects of beta-blockade, such an investigation would not be technically feasible. When both our groups are considered separately, it appears that the linear regression coefficients ( The analysis of our patient data reported here indicates that the ejection fraction and end-diastolic volume index are poorly correlated, and do not exhibit a hyperbola-like relation. This finding indicates that the relation between the ejection fraction and enddiastolic volume index is not necessarily hyperbolic as claimed by some investigators,57 while denied by others. ' In addition, the ejection fraction is far better (p<00005) related to end-systolic volume index than to end-diastolic volume index (see Table) . For purposes of comparison it is essential to consider identical measurement techniques.9 Assumptions concerning geometry of the cavity certainly will affect2 the estimates of end-systolic and end-diastolic volume indexes. Thus, the precise values of the regression coefficients may depend on the particular technique employed to determine left ventricular volume. Notwithstanding the variety of methods used by various investigators, we9 always found an excellent correlation between the ejection fraction and end-systolic volume index. This study is unique with respect to the detection of a particular effect of adrenergic control on left ventricular volume in man. The simple relation established in this study cannot be explained merely on Relations between ejection fraction and venticular volume mathematical grounds. A priori, there is no reason to assume that the ejection fraction is an explicit function of end-systolic volume index only, almost independent of preload (end-diastolic volume index). Obviously, according to its definition formula, ejection fraction would be exactly linearly related to end-systolic volume index only if end-diastolic volume index is constant. Since end-systolic and end-diastolic volume indices usually vary in an unpredictable manner, the relation found is not obvious, and requires the involvement ofa regulatory mechanism, which, at least partially, possibly resides in the sympathetic nervous system. This explanation follows from the decreased correlation between the ejection fraction and end-systolic volume index observed in our group of patients under chronic adrenergic blockade, as well as from information916 derived from denervated hearts, where we noticed that the relation between the ejection fraction and endsystolic volume index was virtually absent. Perhaps the mechanism for relating the ejection fraction to end-systolic volume index originates from the synchrony of contraction, which, for example, is enhanced during sympathetic stimulation of the heart as shown by Randall and Kelso. I Elsewhere,9
II we have collected ample evidence that the end-systolic volume index is a more basic index of cardiac performance: it is the final determinant of the pressure-volume loop once pre-and afterload conditions are given; it characterises the left ventricular function curve, and it is the key variable of the systolic elastance index. Our notion concerning the importance of the end-systolic volume index is supported by the study of Borow et al.,'8 who inferred that it reflects myocardial contractility, and showed that in patients with valvular regurgitation it was a useful predictor of mortality and postoperative left ventricular function. These investigators also noted that neither preoperative end-diastolic volume index nor ejection fraction were statistically significant predictors, in contrast to the end-systolic volume index. In addition, other investigators8 1' have emphasised the prominent role of end-systolic volume index in the analysis of left ventricular performance. The above arguments, along with the documented importance'0 12 of systolic elastance indices, enhance the crucial role played by end-systolic volume for the determination ofthe performance ofthe heart. The high correlation between the ejection fraction and end-systolic volume index documented in this study suggests that both variables are not only mathematically, but also functionally interconnected, if indeed the beta-adrenergic system is operating normally.
Since, in the past, no rationale other than empirical observations has been provided to promote ejection fraction as an index of pump performance, it is conceivable that the applicability ofthe ejection fraction in fact stems from this simple relation between the ejection fraction and end-systolic volume index. The lower correlation found after adrenergic blockade may also explain the inadequacy3 of the ejection fraction to judge left ventricular performance under such circumstances, as well as being the clue to the current controversy4'8 as to whether ejection fraction is a universal and unambiguous index of cardiac performance.
Consequently, it is necessary to scrutinise the relative importance of the ejection fraction and end-systolic volume index, especially in cases when the relation between the two variables is not precisely defined, as for example after beta-blockade or after denervation. Beta-blockers are widely used, for example, in patients with classic angina, with an estimated abundance of 70 to 80% according to a recent review,'9 and 690/o in our patient group described here. This study indicates that these drugs induce a significant dissociation ofthe connection between ejection fraction and end-systolic volume index. Consequently, it is important to focus attention on end-systolic volume index89'8 and related indices9'2 of cardiac performance, rather than on the derived variable ejection fraction as was done in the past during volumetric analysis of left ventricular function in patients, including those under beta-adrenergic blockade. 
